News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
148 Results
Type
Article (2)
Press Release (146)
Section
Business (29)
Deals (5)
Drug Development (16)
News (52)
Policy (4)
Tag
Alliances (2)
Clinical research (15)
COVID-19 (1)
C-suite (1)
Diagnostics (1)
Earnings (1)
Events (8)
Funding (4)
Infectious disease (1)
IPO (4)
Manufacturing (1)
MASH (1)
Mergers & acquisitions (1)
Metabolic disorders (1)
Northern California (1)
People (27)
Phase I (3)
Phase II (12)
Regulatory (4)
United States (2)
Date
Last 7 days (1)
Last 30 days (10)
Last 365 days (29)
2025 (18)
2024 (13)
2023 (25)
2022 (32)
2021 (24)
2020 (3)
2019 (10)
2017 (4)
2016 (5)
2015 (14)
Location
Asia (1)
California (1)
Canada (13)
Europe (1)
Northern California (1)
Puerto Rico (1)
148 Results for "hemostemix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemostemix’s Social Media Awareness of “Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction
Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating individuals about treatments and advancements.
January 2, 2025
·
6 min read
Press Releases
Hemostemix Provides Corporate Update
February 14, 2025
·
6 min read
Press Releases
Hemostemix Licenses CytoImmune’s BioReactor Technologies
February 19, 2025
·
9 min read
Press Releases
Hemostemix Expands to the Dominican Republic
February 3, 2025
·
6 min read
Press Releases
RETRANSMISSION: Hemostemix Licenses CytoImmune’s BioReactor Technologies
February 20, 2025
·
9 min read
Press Releases
Hemostemix Up-lists to TradeGateExchange in Germany
January 28, 2025
·
7 min read
Press Releases
Hemostemix Announces Grant of Stock Options
January 22, 2025
·
6 min read
Press Releases
Hemostemix Contracts ProConsul to Ramp up Engagement with New Investors
February 10, 2025
·
5 min read
Press Releases
Hemostemix Announces the Incorporation of Hemostemix PR Inc: 50% Reimbursement of R&D Expenses in Cash
January 6, 2025
·
9 min read
Press Releases
Hemostemix Announces First Sales Orders for ACP-01
January 29, 2025
·
5 min read
1 of 15
Next